Physician
Infectious Disease
Dr. Judith C. Falloon, MD
|
|
Give Review
Judith C. Falloon practices Infectious Disease. She researched medicine at University of Maryland School of Medicine. University of Maryland School of Medicine has a rank of 37 in research and a 52 in primary care Doctor Judith C. Falloon, MD is also a published doctor. She has 94 publication published. The most recent publication is: Alteration in indinavir clearance during interleukin-2 infusions in patients infected with the human immunodeficiency virus.
Publications
- Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy.
- A potential role for interleukin-7 in T-cell homeostasis.
- Immunotherapy of HIV-infected patients with intermittent interleukin-2: effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion.
- Salvage antiretroviral therapy.
- Relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at c...
- Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression.
- Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression.
- Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.
- Indinavir concentrations and St John''s wort.
- Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokine...
- High-level resistance to 3'-azido-3'-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1.
- HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression.
- Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study.
- Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after in...
- Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
- JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1.
- Time to genotype for selection of antiretroviral regimens in previously treated patients?
- Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy.
- A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection.
- A multiple drug interaction study of stavudine with agents for opportunistic infections in human immunodeficiency virus-infected patients.
- Alteration in indinavir clearance during interleukin-2 infusions in patients infected with the human immunodeficiency virus.
- Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults.
- Visceral abdominal-fat accumulation associated with use of indinavir.
- Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire.
- Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.
- Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection.
- Symptomatic appendiceal wall thickening in an HIV-infected patient caused by interleukin-2 therapy.
- Crystalluria and urinary tract abnormalities associated with indinavir.
- HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based ...
- Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons.
- Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection.
- Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.
- Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infecte...
- Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1.
- Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trial.
- Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.
- Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet).
- Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.
- Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virus.
- NIH conference. Recent advances in the management of AIDS-related opportunistic infections.
- A unique syndrome of immunodeficiency and autoimmunity associated with absent T cell CD2 expression.
- Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria.
- Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.
- Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.
- Immunochemical evidence for a novel pertussis toxin substrate in human neutrophils.
- Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease.
- Detection of the major pertussis toxin substrate of human leukocytes with antisera raised against synthetic peptides.
- Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection.
- Neutrophil granules in health and disease.
- Separation and function of neutrophil karyogranuloplasts and comparison with cytoplasts and intact cells.
- Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)
- Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.
- Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.
- The pharmacokinetics of zidovudine administered by continuous infusion in children.
- Human immunodeficiency virus infection in children.
- CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.
- Thin-walled cavities, cysts, and pneumothorax in Pneumocystis carinii pneumonia: further observations with histopathologic correlation.
- Current treatment for human immunodeficiency virus infection.
- Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.
- The era of aerosol pentamidine prophylaxis: the beginning or the end?
- Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.
- A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome.
- A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infect...
- Brain growth and cognitive improvement in children with human immunodeficiency virus-induced encephalopathy after 6 months of continuous infusion zidovudine therapy.
- A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.
- Current therapy for HIV infection and its infectious complications. A practical summary for primary care physicians.
- Phase I/II studies of the toxicity and immunogenicity of recombinant gp160 and p24 vaccines in HIV-infected individuals.
- Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposure.
- Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.
- The effect of garlic supplements on the pharmacokinetics of saquinavir.
- A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
- Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children.
- A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in hea...
- An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years.
- Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors.
- Cryptococcosis and idiopathic CD4 lymphocytopenia.
- Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7.
- Lack of in vivo correlation between indinavir and saquinavir exposure and cytochrome P450 3A phenotype as assessed with oral midazolam as a phenotype probe.
- Functional correlation between a novel amino acid insertion at codon 19 in the protease of human immunodeficiency virus type 1 and polymorphism in the p1/p6 Gag cleava...
- Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort.
- Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy.
- Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.
- Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection.
- Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.
- Vaccination in humans generates broad T cell cytokine responses.
- Ritonavir decreases the nonrenal clearance of digoxin in healthy volunteers with known MDR1 genotypes.
- A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency ...
- Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen.
- HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients recei...
- High prevalence of osteonecrosis of the femoral head in HIV-infected adults.
- Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers.
- Indinavir-associated interstitial nephritis and urothelial inflammation: clinical and cytologic findings.
- HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients.
Schools
University of Maryland At Baltimore Professional Schools
Barnes Jewish Hospital
National Institute Of Health
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
Washington University - Barnes-Jewish Hospital -
University of Maryland School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Helene F. Rosenberg, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Thomas A. Cardella, MD |
|
|
Dr. Drake H. Tilley Jr., MD |
|
|
Dr. Cindy Tamminga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Sanders III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas L. Mayers, MD |
|
|
Dr. Gregory A. Deye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janine R. Danko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Koup, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Barney S. Graham, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Caryn G. Morse, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Siddhartha Mahanty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane H. Chretien, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roseanne A. Ressner, DO |